Why understanding the differences between Type 1 and Type 2 diabetes is essential for better health management and effective ...
11d
Interesting Engineering on MSNFDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentFirst-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
Discover how hormone therapy during menopause may improve heart, metabolic, and bone health while reshaping overall ...
Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID ...
The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...
Transplanting insulin-producing cells along with engineered blood-vessel-forming cells has successfully reversed type 1 ...
Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.
Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...
A UK-based study reveals that a reduced-energy diet in late pregnancy is perfectly beneficial and safe for women with ...
Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results